Mangaluru: Basheer who was attacked by hatemongers loses battle for life

Bengaluru, Mar 22: People here stayed at their homes due to Janata Curfew on Sunday amid the coronavirus scare.

Prime Minister Narendra Modi had on Thursday urged people to stay at their homes as a precautionary measure against the spread of coronavirus.

"In such difficult times, all Indians are supporting the cause. We accept and obey the Prime Minister's orders wholeheartedly as it is about how we protect ourselves and keep our children safe from this disease," said Shashikant Varma, a resident of Bengaluru.

"We hope the situation gets better at earliest and everyone gets rid of the virus," Varma added.
"All the shops have been closed.Everyone is at their homes to avoid getting infected from this deadly virus," said Harish Niwasi, another resident.

"Today is PMs Janata Curfew and so we all are at home. I appeal to all that by staying at home we can save each other from the deadly virus. We thank the PM for guiding us at such difficult times," said Tulsi Ram Varma.

The Janata curfew which began at 7 am today will come to an end at 9 pm.

Till now, the total number of positive coronavirus cases in Karnataka is 15 out of which one person has been cured and one death has taken place in the state, according to the Health Ministry.

The Karanataka Health Department on Saturday confirmed five new coronavirus cases in the state, taking the total count to 20.

According to the Indian Council of Medical Research (ICMR), till now there are 341 positive cases of coronavirus in the country.

New Delhi, Jun 6: Military commanders of India and China are scheduled to meet today at Moldo on the Chinese side of the Line of Actual Control (LAC), to discuss the ongoing dispute along the LAC in Eastern Ladakh.

The Commander of the Leh-based 14 Corps of the Indian Army Commander Lieutenant Gen Harinder Singh will meet his Chinese equivalent Maj Gen Liu Lin, who is the commander of South Xinjiang Military Region of Chinese People's Liberation Army (PLA) to address the ongoing tussle in Eastern Ladakh between the two countries over the heavy military build-up by the People's Liberation Army along the LAC there.

The two sides have held close to a dozen rounds of talks since the first week of May when the Chinese sent over 5,000 troops to the LAC.

On Friday, officials of India and China interacted through video-conferencing with the two sides agreeing that they should handle "their differences through peaceful discussion" while respecting each other's sensitivities and concerns and not allowing them to become disputes in accordance with the guidance provided by the leadership.

In the last few days, there has not been any major movement of the People's Liberation Army troops at the multiple sites where it has stationed itself along the LAC opposite Indian forces.

India and China have been locked in a dispute over the heavy military build-up by the People's Liberation Army (PLA) where they have brought in more than 5,000 troops along with the Eastern Ladakh sector.

The Chinese Army's intent to carry out deeper incursions was checked by the Indian security forces by quick deployment. The Chinese have also brought in heavy vehicles with artillery guns and infantry combat vehicles in their rear positions close to the Indian territory.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.